ESSA Pharma News

ESSA Pharma | SCHEDULE 13G/A: Others

Feb 14 16:52 ET

ESSA Pharma | SCHEDULE 13G/A: Others

Feb 14 10:29 ET

ESSA Pharma | SCHEDULE 13G/A: Others

Feb 14 09:54 ET

ESSA Pharma | SCHEDULE 13G/A: Others

Feb 14 09:05 ET

ESSA Pharma | SCHEDULE 13G/A: Others

Feb 11 16:01 ET

ESSA Pharma | 8-K: ESSA Pharma Reports Financial Results for Fiscal First Quarter Ended December 31, 2024

Feb 11 07:06 ET

ESSA Pharma | 10-Q: Q1 2025 Earnings Report

Feb 11 07:01 ET

ESSA Pharma | DEFA14A: Others

Jan 22 16:21 ET

ESSA Pharma | DEF 14A: Definitive information statements

Jan 22 16:17 ET

ESSA Pharma | 8-K: ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024

Dec 17, 2024 07:08 ET

ESSA Pharma | 10-K: FY2024 Annual Report

Dec 17, 2024 07:03 ET

ESSA Pharma | 8-K: Current report

Dec 16, 2024 06:12 ET

ESSA Pharma | 8-K: Current report

Dec 6, 2024 07:04 ET

ESSA Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BB Biotech AG(0.0%),Biotech Growth N.V. N/A(0.0%)

Nov 14, 2024 19:37 ET

ESSA Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-PFM Health Sciences, LP(6.2%),PFM Health Sciences GP, LLC(6.2%), etc.

Nov 14, 2024 17:23 ET

ESSA Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RTW Investments, LP(7.4%),Roderick Wong, M.D.(7.4%)

Nov 14, 2024 07:02 ET

ESSA Pharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-TANG CAPITAL MANAGEMENT, LLC(9.7%),KEVIN TANG(9.7%), etc.

Nov 8, 2024 17:00 ET

ESSA Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-BML Investment Partners, L.P.(9.4%)

Nov 7, 2024 12:54 ET

ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-10% Owner BIOTECH GROWTH N V

Nov 5, 2024 12:11 ET

ESSA Pharma | 8-K: Current report

Nov 1, 2024 16:33 ET